These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12547991)

  • 1. Cutaneous arteriolar thioredoxin expression in patients with heart failure.
    Miyamoto M; Kishimoto C; Shioji K; Lee JD; Shimizu H; Ueda T; Yodoi J
    Circ J; 2003 Feb; 67(2):116-8. PubMed ID: 12547991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of arteriolar hyalinosis of the skin of patients with chronic congestive heart failure.
    Kishimoto C; Shioji K; Ito H; Kinoshita M; Lee JD; Shimizu H; Ueda T
    Circ J; 2002 Apr; 66(4):382-4. PubMed ID: 11954954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Wroblewski H; Kastrup J; Nørgaard T; Mortensen SA; Haunsø S
    Am J Cardiol; 1992 Mar; 69(8):769-74. PubMed ID: 1372144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thioredoxin (TRX) levels in patients with heart failure.
    Kishimoto C; Shioji K; Nakamura H; Nakayama Y; Yodoi J; Sasayama S
    Jpn Circ J; 2001 Jun; 65(6):491-4. PubMed ID: 11407728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Takahashi H; Kadowaki S; Narumi T; Honda Y; Wanezaki M; Sasaki S; Tamura H; Nishiyama S; Arimoto T; Shishido T; Miyamoto T; Kubota I
    J Cardiol; 2014 Nov; 64(5):353-9. PubMed ID: 24685687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of redox-regulating protein, thioredoxin, in endomyocardial biopsy samples of patients with myocarditis and cardiomyopathies.
    Nimata M; Kishimoto C; Shioji K; Ishizaki K; Kitaguchi S; Hashimoto T; Nagata N; Kawai C
    Mol Cell Biochem; 2003 Jun; 248(1-2):193-6. PubMed ID: 12870673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin microvascular distensibility and structural microangiopathy in idiopathic dilated cardiomyopathy and after heart transplantation.
    Sørensen VB; Wroblewski H; Galatius S; Nørgaard T; Haunsø ; Kastrup J
    Microvasc Res; 1999 Jan; 57(1):44-51. PubMed ID: 9882561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
    Satoh M; Matter CM; Ogita H; Takeshita K; Wang CY; Dorn GW; Liao JK
    Circulation; 2007 Jun; 115(25):3197-204. PubMed ID: 17562954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular distensibility in two different vascular beds in idiopathic dilated cardiomyopathy.
    Wroblewski H; Nørgaard T; Haunsø S; Kastrup J
    Am J Physiol; 1995 Dec; 269(6 Pt 2):H1973-80. PubMed ID: 8594906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy.
    Watanabe E; Matsuda N; Shiga T; Kajimoto K; Ajiro Y; Kawarai H; Kasanuki H; Kawana M
    J Card Fail; 2006 Sep; 12(7):527-32. PubMed ID: 16952786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal baroreceptor-mediated vasodilation of the peripheral circulation in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Wroblewski H; Kastrup J; Mortensen SA; Haunsø S
    Circulation; 1993 Mar; 87(3):849-56. PubMed ID: 8443905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.
    Tsutsui T; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Ohnishi M; Kinoshita M
    J Am Coll Cardiol; 2002 Mar; 39(6):957-62. PubMed ID: 11897436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.
    Nonaka-Sarukawa M; Yamamoto K; Aoki H; Takano H; Katsuki T; Ikeda U; Shimada K
    Heart; 2003 Aug; 89(8):871-4. PubMed ID: 12860861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution.
    Martinez-Pinna R; Lindholt JS; Blanco-Colio LM; Dejouvencel T; Madrigal-Matute J; Ramos-Mozo P; Vega de Ceniga M; Michel JB; Egido J; Meilhac O; Martin-Ventura JL
    Atherosclerosis; 2010 Sep; 212(1):333-8. PubMed ID: 20609439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease.
    de Boer RA; Henning RH; Suurmeijer AJ; Pinto YM; Olthof E; Kirkels JH; van Gilst WH; Crijns HJ; van Veldhuisen DJ
    Int J Cardiol; 2001 Mar; 78(1):5-12. PubMed ID: 11259807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure.
    Krüger S; Graf J; Merx MW; Stickel T; Kunz D; Hanrath P; Janssens U
    Int J Cardiol; 2004 May; 95(1):49-54. PubMed ID: 15159038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxins in cardiovascular disease.
    Whayne TF; Parinandi N; Maulik N
    Can J Physiol Pharmacol; 2015 Nov; 93(11):903-11. PubMed ID: 26417924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment.
    Genc A; Kalelioglu T; Karamustafalioglu N; Tasdemir A; Gungor FC; Genc ES; Incir S; Ilnem C; Emul M
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):344-50. PubMed ID: 25297388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Waon therapy on oxidative stress in chronic heart failure.
    Fujita S; Ikeda Y; Miyata M; Shinsato T; Kubozono T; Kuwahata S; Hamada N; Miyauchi T; Yamaguchi T; Torii H; Hamasaki S; Tei C
    Circ J; 2011; 75(2):348-56. PubMed ID: 21173495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.